Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Sree Rayalaseema Hi-Strength Hypo Limited ₹753, price ₹544, upside +38.5%, quality 69 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Sree Rayalaseema Hi-Strength Hypo Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range ₹271.08 – ₹894.06 · fair‑value band ₹567.02 – ₹950.88 · the ₹543.60 price screens below the ₹752.87 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Sree Rayalaseema Hi-Strength Hypo in your weekly email
Every Wednesday you see whether Sree Rayalaseema Hi-Strength Hypo is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal.
Show more
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; purichlor, chloramine, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatment chemicals. It is involved in the generation and distribution of power through thermal, wind, and solar plants; and coal trading business. The company also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.
Stock analysis
Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) currently trades at ₹543.60, while our model-based Fair Value estimate is ₹752.87, implying the stock looks roughly 27.8% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹838.25 per share, and 18 of the 26 models we run sit above the ₹543.60 price.
Bear case: the Earnings-Based group reads lowest at ₹343.99, and 8 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹567.02 (bear) to ₹950.88 (bull), the price of ₹543.60 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of ₹6.7B in FY2026 versus ₹12.6B in FY2022, a compound −14.7%/yr. Reported net income was ₹901M in FY2026, compounding −3.2%/yr from FY2022.
Key figures
Market cap ₹9.2B (≈ $95.6M) · P/E ratio 9.9 · P/S ratio 1.34 · EPS (TTM) ₹54.70 · Dividend yield 0.6% · Net margin 13.5% · Return on equity 9.4% · Return on assets (EBIT) 15.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 42% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at 39%, SRHHYPOLTD screens cheaper than that median.
Fair Value models
Bear ₹567.02Fair Value ₹752.87Bull ₹950.88
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹26.20 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.73/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+9.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.6%
Dividend (yield on the price)0.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.8.6% vs 15.0%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 12%
Start year 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −6.2% a year for the price.
Compare Sree Rayalaseema Hi-Strength Hypo Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 342 stocks
Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside+38.5% · Top 25%
Profitability
Return on equity (TTM)9.4% · Above median
Return on assets4.7% · Above median
Net margin (TTM)13.2% · Top 25%
Operating margin (TTM)13.3% · Above median
Growth and dividend
Revenue growth17.0% · Above median
Dividend yield (TTM)0.6% · Bottom 25%
Valuation Multiplesvs Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of ₹752.87 versus a price of ₹543.60, about +39% upside (undervalued).
What is the fair value of SRHHYPOLTD?
Our model-based fair value for Sree Rayalaseema Hi-Strength Hypo Limited is ₹752.87 (as of Oct 2, 2026), built from audited fundamentals. The current price: ₹543.60.
What is the quality score of SRHHYPOLTD?
Sree Rayalaseema Hi-Strength Hypo Limited has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Our model-based price target is the fair value of ₹752.87 (as of Oct 2, 2026) from 26 valuation models. Cautious scenario ₹567.02, optimistic scenario ₹950.88. It is a calculation from audited fundamentals, not an analyst target.
What is the Sree Rayalaseema Hi-Strength Hypo Limited stock forecast for 2026?
Our models put fair value at ₹752.87, about +39% upside versus a price of ₹543.60 (undervalued). Cautious scenario ₹567.02, optimistic scenario ₹950.88. The calculation is refreshed regularly with new filings.
What is the revenue of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Sree Rayalaseema Hi-Strength Hypo Limited reported trailing-twelve-month revenue of about ₹7.0B (latest available figure, as of Oct 2, 2026).
Does Sree Rayalaseema Hi-Strength Hypo Limited pay a dividend?
Sree Rayalaseema Hi-Strength Hypo Limited currently shows a dividend yield of about 0.55% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
For today's price to be fair in a discounted-cash-flow model, Sree Rayalaseema Hi-Strength Hypo Limited would have to grow free cash flow by -2.3 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -6.0 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of SRHHYPOLTD use?
Our models discount Sree Rayalaseema Hi-Strength Hypo Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.44, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sree Rayalaseema Hi-Strength Hypo Limited that is -2.3 % per year a year over ten years, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) delivered so far?
Over the past 5 years revenue at Sree Rayalaseema Hi-Strength Hypo Limited grew -6.0 % a year. The price currently implies -2.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) growing?
The median revenue growth in the sector is +6.6 % a year. That is the yardstick for the growth priced into Sree Rayalaseema Hi-Strength Hypo Limited (-2.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The free-cash-flow yield on the price is 7.54 %: that much free cash flow Sree Rayalaseema Hi-Strength Hypo Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sree Rayalaseema Hi-Strength Hypo Limited it is ₹752.87 per share (as of Oct 2, 2026), against a price of ₹543.60. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Sree Rayalaseema Hi-Strength Hypo Limited stock overvalued or undervalued in 2026?
As of Oct 2, 2026, SRHHYPOLTD trades below its calculated fair value: price ₹543.60, fair value ₹752.87, a gap of about +39% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SRHHYPOLTD?
No. The price is what the market pays today (₹543.60); the fair value is what the company's own numbers justify (₹752.87). For Sree Rayalaseema Hi-Strength Hypo Limited the two are ₹209.27 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sree Rayalaseema Hi-Strength Hypo Limited worth?
The market values Sree Rayalaseema Hi-Strength Hypo Limited at about ₹9.2B (market capitalisation, as of Oct 2, 2026). Per share that is ₹543.60; our models calculate a fair value of ₹752.87 per share.
What do the bullish and bearish scenarios say about SRHHYPOLTD?
Our models span a range for Sree Rayalaseema Hi-Strength Hypo Limited: cautious scenario ₹567.02, base ₹752.87, optimistic ₹950.88 per share (as of Oct 2, 2026, price ₹543.60). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SRHHYPOLTD?
Sree Rayalaseema Hi-Strength Hypo Limited trades at a price-to-earnings ratio of 9.9 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹752.87 is built from several models across several years. Other multiples: P/B 1.0, P/S 1.3, EV/EBITDA 5.3.
How solid is the balance sheet of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Balance-sheet figures for Sree Rayalaseema Hi-Strength Hypo Limited (as of Oct 2, 2026): return on equity 9.4%. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is SRHHYPOLTD from its 52-week high?
Sree Rayalaseema Hi-Strength Hypo Limited trades at ₹543.60, about 13% below its 52-week high of ₹627.70 and 42% above the low of ₹384.00 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹752.87 is for.
Which stocks are comparable to Sree Rayalaseema Hi-Strength Hypo Limited?
From the same area (Basic Materials) we also value Ningxia Baofeng Energy Group, Dow Inc, Hengli Petrochemical Co, Zangge Mining Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sree Rayalaseema Hi-Strength Hypo Limited stock attractive at the current price?
The data as of Oct 2, 2026: price ₹543.60, calculated fair value ₹752.87 (+39%), Quality Score 69/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SRHHYPOLTD calculated?
We run Sree Rayalaseema Hi-Strength Hypo Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹752.87, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Sree Rayalaseema Hi-Strength Hypo Limited currently trades 28 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The closing price on Oct 1, 2026 was ₹543.60. Our model-based fair value is ₹752.87, about +39% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sree Rayalaseema Hi-Strength Hypo Limited right now?
The price is below even our cautious bear case (₹567.02). The market is more pessimistic than our downside scenario. Solid quality (69/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) come from?
Earnings per share at Sree Rayalaseema Hi-Strength Hypo Limited grew +15.7 % a year from 2015 to 2026. Broken into its drivers: revenue per share +6.5 %, EBIT margin +6.5 %, tax rate −1.8 %, residual (interest, one-offs) +3.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Sree Rayalaseema Hi-Strength Hypo Limited
How large is the market capitalisation of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The market capitalisation of Sree Rayalaseema Hi-Strength Hypo Limited is ₹9.2B (≈ $95.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The price-to-sales ratio of Sree Rayalaseema Hi-Strength Hypo Limited is 1.34 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Earnings per share at Sree Rayalaseema Hi-Strength Hypo Limited are ₹54.70 (price ÷ EPS = P/E 9.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The dividend yield of Sree Rayalaseema Hi-Strength Hypo Limited is 0.6% (payout 5.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The net margin of Sree Rayalaseema Hi-Strength Hypo Limited is 13.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The return on equity (ROE) of Sree Rayalaseema Hi-Strength Hypo Limited is 9.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
On an EBIT basis the return on assets of Sree Rayalaseema Hi-Strength Hypo Limited is 15.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
The operating margin of Sree Rayalaseema Hi-Strength Hypo Limited is 13.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Revenue at Sree Rayalaseema Hi-Strength Hypo Limited is growing +17.0% versus a year earlier (3y avg −26.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
Earnings per share at Sree Rayalaseema Hi-Strength Hypo Limited are growing +11.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) hold?
Sree Rayalaseema Hi-Strength Hypo Limited holds more cash than debt, ₹4.3B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Sree Rayalaseema Hi-Strength Hypo Limited in the live analysis
One click puts Sree Rayalaseema Hi-Strength Hypo Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
